Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected] - Test2 - elhamkhani - TriplyDB

Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]

Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]

http://www.wikidata.org/entity/Q33873730

about

Nanosizing of drugs: Effect on dissolution rate Preparation and Characterization of Naringenin-Loaded Elastic Liposomes for Topical Application History, Global Distribution, and Nutritional Importance of Citrus Fruits Naringenin Impairs Two-Pore Channel 2 Activity And Inhibits VEGF-Induced Angiogenesis.Naringenin modulates skeletal muscle differentiation via estrogen receptor α and β signal pathway regulation Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3 Preparation of naringenin/ β-cyclodextrin complex and its more potent alleviative effect on choroidal neovascularization in rats.A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts PPARα in lysosomal biogenesis: A perspective.Flavonoids as dietary regulators of nuclear receptor activity Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems.Chemopreventive and therapeutic potential of "naringenin," a flavanone present in citrus fruits.Supramolecular cyclodextrin-based drug nanocarriers.Gold nanoparticles stabilized with βcyclodextrin-2-amino-4-(4-chlorophenyl)thiazole complex: A novel system for drug transport.Neuroprotective and Cognitive-Enhancing Effects of Microencapsulation of Mulberry Fruit Extract in Animal Model of Menopausal Women with Metabolic Syndrome.Scientific Opinion of Flavouring Group Evaluation 410 (FGE.410): 4’,5,7‐trihydroxyflavanone from chemical group 25 (phenol derivatives containing ring‐alkyl, ring‐alkoxy, and side‐chains with an oxygenated functional group)Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events.Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.Comparative Study between Ethanolic and β-Cyclodextrin Assisted Extraction of Polyphenols from Peach Pomace.

P2860

Q26781058-C171E4C9-8CF4-46AB-A937-107B30F08F48 Q28546409-4F30261A-E97D-407E-98F2-23BCF336ED9E Q29541428-A4345758-4822-46ED-A542-0758B231E0B4 Q33894915-4DBF5412-8B95-452A-A981-65B2E7181493 Q34232706-54C64387-DB48-42A6-9327-CF10ED52B043 Q34494310-A08F88AA-97F0-4EFD-B725-59C223E9944F Q35162838-6D57FEF5-60CA-43D3-BF33-C02196235EBA Q36024969-07F6161B-90A2-4B3E-AC35-7A9BBFE9487D Q36885041-8700E23E-99C5-4DB3-B187-02C367CF34BE Q37193003-54BA4232-D7BE-4119-90E1-940C9F28A4C2 Q38181489-CB941A67-76ED-4555-9DEC-B3232C2D5074 Q38290573-536CB2F9-F85A-4E0C-9F28-B197D54566C6 Q38354545-B2CE889D-9F41-454D-9B64-73E27930A343 Q42705283-9FFA1812-0867-4B47-8EA8-8F11A3E26126 Q47160692-0C302B3E-BF46-4C51-AB87-C9E3916E6DAB Q47160909-28C25E88-572E-43A2-BF98-53D1AA2B7D21 Q53160636-F8FA945E-F3BA-4387-B3BF-E35B63D85EAE Q53268665-A2606FCD-1370-41E1-990F-E6752EEE6783 Q54342604-0CA01BF6-3A5D-45C4-9956-1487EBBB2DC8 Q55312020-8132C9DF-93E4-4CD1-A214-15D0734FA0EC

P2860

Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]

http://www.wikidata.org/entity/Q33873730

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Enhancement of naringenin bioa ...... yl-β-cyclodextrin. [corrected]

@ast

Enhancement of naringenin bioa ...... yl-β-cyclodextrin. [corrected]

@en

type

label

Enhancement of naringenin bioa ...... yl-β-cyclodextrin. [corrected]

@ast

Enhancement of naringenin bioa ...... yl-β-cyclodextrin. [corrected]

@en

prefLabel

Enhancement of naringenin bioa ...... yl-β-cyclodextrin. [corrected]

@ast

Enhancement of naringenin bioa ...... yl-β-cyclodextrin. [corrected]

@en

P1433

Q33873730-031B9D96-6E9B-442A-AC15-30148D6A39A5

P1476

Q33873730-39E26CC4-D915-4A08-A887-3C7DF0142984

P2093

Q33873730-32DFBA98-6664-4864-A085-C695311D2A9F

Q33873730-383F219C-E43B-4014-8694-4110CD8490DB

Q33873730-4622643E-3805-40FD-85FE-C72FFA7A0467

Q33873730-67CAEFF8-722F-4CDB-9D7F-7BEF530A9833

Q33873730-7ACC035D-8348-41AB-B268-F17A4A963AA2

Q33873730-B9FC2128-DC72-4B48-9E24-E6868C593A92

Q33873730-C1B8EEED-ED23-4DD4-8EAD-0E3F929FCDE2

Q33873730-CD04CB99-7092-49C3-8C60-50A8F3DD5DD7

Q33873730-D23EF595-F3B6-46FA-AD37-2C9623A706D5

Q33873730-F9F835AA-3900-428D-976B-238EA45C9FDC

P2860

Q33873730-071D1034-0A09-42AA-92F4-7D96B6C79003

Q33873730-09F44D98-5522-47A8-BF5E-E5DEA9969E2A

Q33873730-1C337D63-422B-4556-9B52-02DBC558BA17

Q33873730-1E840733-85A3-45D0-8D4D-1D808EDD23DA

Q33873730-298B9704-C7EE-4B4D-BAD7-C66402511184

Q33873730-2DEB030A-09BC-4250-B228-9EB1923F823D

Q33873730-3A8055E4-54FD-4735-A6A9-7464F41F7299

Q33873730-4278D02B-A356-4199-9028-519B9AB9DC32

Q33873730-48C63466-C27B-4A38-B8CC-5F64D2477084

Q33873730-4FBB76CA-9DDA-4CE1-B4C0-D09EB1F28DC5

P304

Q33873730-3F835B99-4D54-483C-A249-B83B7FDA7083

P31

Q33873730-5016928F-3E2A-4693-A73D-65310DE85B7C

P356

Q33873730-3305EFA0-5452-49B9-8D00-ADE5996980FD

P407

Q33873730-764E774D-67E5-407C-9790-87F1A34109A7

P433

Q33873730-64CA71B0-F90A-4CFF-9CF9-2F0943358652

P478

Q33873730-A85492B3-5C59-4F54-9751-C70DFDD613DF

P577

Q33873730-DD476DA7-2D71-4B00-8E9D-FB31C9211AC7

P5875

Q33873730-730DDAAB-CCA2-4E73-AE4D-74E8E5F63A44

P698

Q33873730-6221D657-8635-49D2-88A6-E894E8253EF0

P932

Q33873730-08AB994D-38FA-47EF-82BD-31E8F14CF564

P356

JOURNAL.PONE.0018033

P1433

P1476

Enhancement of naringenin bioa ...... yl-β-cyclodextrin. [corrected]

@en

P2093

Alejandro Soto-Gutierrez

http://www.w3.org/2001/XMLSchema#string

Carolyn W Lee-Parsons

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yagi

http://www.w3.org/2001/XMLSchema#string

Hongyun Wang

http://www.w3.org/2001/XMLSchema#string

Jonathan Goldwasser

http://www.w3.org/2001/XMLSchema#string

Maria Shulman

http://www.w3.org/2001/XMLSchema#string

Martin L Yarmush

http://www.w3.org/2001/XMLSchema#string

Merav Cohen

http://www.w3.org/2001/XMLSchema#string

Ofra Benny-Ratsaby

http://www.w3.org/2001/XMLSchema#string

Yaakov Nahmias

http://www.w3.org/2001/XMLSchema#string

P2860

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance

The fate of naringin in humans: a key to grapefruit juice-drug interactions?

Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation.

Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice.

Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha.

The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics.

Cyclodextrins in drug delivery: an updated review

Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids.

Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.

P304

e18033

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0018033

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51052771

http://www.w3.org/2001/XMLSchema#string

P698

21494673

http://www.w3.org/2001/XMLSchema#string

P932

3071816

http://www.w3.org/2001/XMLSchema#string